Madrigal Pharmaceuticals
MDGL
#1596
Rank
HK$100.45 B
Marketcap
HK$4,423
Share price
-1.51%
Change (1 day)
78.54%
Change (1 year)

Earnings for Madrigal Pharmaceuticals (MDGL)

Earnings in 2025 (TTM): -HK$2.12 Billion

According to Madrigal Pharmaceuticals 's latest financial reports the company's current earnings are HK$0.74 Billion. In 2024 the company made an earning of -HK$3.52 Billion a decrease over its 2023 earnings that were of -HK$2.81 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Madrigal Pharmaceuticals from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$2.12 Billion-39.74%
2024 -HK$3.52 Billion25.02%
2023 -HK$2.81 Billion23.86%
2022 -HK$2.27 Billion20.24%
2021 -HK$1.89 Billion17.25%
2020 -HK$1.61 Billion117.61%
2019 -HK$0.74 Billion189.45%
2018 -HK$0.26 Billion3.85%
2017 -HK$0.25 Billion25.71%
2016 -HK$0.2 Billion-50.81%
2015 -HK$0.4 Billion-39.14%
2014 -HK$0.66 Billion-4.12%
2013 -HK$0.69 Billion
2011 -HK$0.36 Billion23.13%
2010 -HK$0.29 Billion-145.81%
2009 HK$0.62 B-185.95%
2008 -HK$0.73 Billion41.52%
2007 -HK$0.52 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-HK$0.15 Billion-93.32%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-HK$1.25 Billion-41.28%๐Ÿ‡บ๐Ÿ‡ธ USA